Dose (Duration) | Predicted DDI (AUCR) | Observed DDI (AUCR) | |||
---|---|---|---|---|---|
R3 | Net Effect | SimCYP | AUCR Change | ||
mg | |||||
Precipitant | |||||
Carbamazepine | 942 | 0.15 | 0.52 | 0.54 | 0.10 |
Cimetidine | 800 | 0.99 | 1.0 | 1.07 | 1.05 |
Efavirenz | 600 | 0.09 | 0.87 | 0.70 | 0.45 |
Nelfinavir | 1250 | 0.21 | 0.80 | 0.90 | 0.92 |
Rifampin | 600 | 0.12 | 0.34 | 0.76 | 0.33 |
600 | 0.12 | 0.34 | 0.68 | 0.33 | |
600 | 0.12 | 0.34 | 0.67 | 0.52 | |
Ritonavir | 100 | 0.20 | 0.95 | 0.90 | 0.78 |
400 | 0.15 | 0.67 | 0.79 | 0.98 | |
600 | 0.16 | 0.75 | 0.74 | 0.34 | |
300 | 0.16 | 0.79 | 0.78 | 0.67 | |
300 (3 d) | 0.16 | 0.79 | 0.89 | 0.84 | |
200 (2 d) | 0.18 | 0.90 | 0.95 | 1.20 | |
Teriflunomide | 14-70 | 0.94 | 1.0 | 0.83 | 0.91 |
Prediction error (GMFE)a | 3.45 | 1.39 | 1.50 | ||
True positives | 100 | 75 | 88 | ||
True negatives | 33 | 67 | 83 | ||
False positives | 67 | 33 | 17 | ||
False negatives | 0 | 25 | 13 |
↵a Percentage of clinical trials that were predicted as false negative, false positive, true negative, or true positive with respect to induction based on the 0.8-fold cutoff criterion.